Your doctor may recommend Zetia for kinds of high cholesterol. It’s a brand-name prescription drug that can be used in adults and some children. Specifically, Zetia can be used with a low cholesterol ...

The evidence says Merck's cholesterol-lowering drug Zetia should be a niche product. It works by a little-understood mode of action. No trials show that it prevents heart attacks. Yet Merck's clever ...

Until last week, Schering-Plough had gone years without delivering any drugs that were more than improvements in existing medications. On Oct. 25 that changed, when the Food and Drug Administration ...

Zetia (ezetimibe) is a brand-name oral tablet prescribed for certain types of high cholesterol. Zetia’s cost, with and without insurance, can depend on several factors, such as whether Zetia has a ...

Add Yahoo as a preferred source to see more of our stories on Google. By Bill Berkrot CHICAGO (Reuters) - After years of uncertainty, a nearly decade-long study showed that Merck & Co's cholesterol ...

Nov 10 (Reuters) - Merck & Co on Monday said long-awaited data from an 18,000-patient trial suggest the company will not have to write down the value of its blockbuster Zetia and Vytorin cholesterol ...

Dr. Allen Taylor, an ARBITER-6 HALT trial investigator, should probably avoid talking to Merck investors for the next few weeks lest he get punched in the nose. It was Allen and his colleagues' ...

Merck & Co.'s big-selling cholesterol-fighter Zetia is at the end of its exclusive road. The $2.5 billion seller now faces its first generic competitor, which threatens not only its own revenue, but ...

Zetia (ezetimibe) is a brand-name oral tablet that’s prescribed for certain forms of high cholesterol in adults and some children. Zetia has interactions with some other drugs. Examples include ...

Despite new US cholesterol guidelines and a clinical trial that tamped down hopes that Merck’s cholesterol drug Zetia could make a difference in the rare disease space, an analysis of prescription ...

NEW ORLEANS, November 8, 2004 – Results from a new study showed that coadministration of ZETIA® (ezetimibe) and fenofibrate significantly reduced LDL ("bad") cholesterol (LDL-C), non-high density ...